ArticleCancers2021

BRAF/EZH2 Signaling Represses miR-129-5p Inhibition of SOX4 Thereby Modulating BRAFi Resistance in Melanoma.

Kathleen Gebhardt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.